AU2004284461A1 - Method for two- and three-dimensional microassembly of patterns and structures - Google Patents
Method for two- and three-dimensional microassembly of patterns and structures Download PDFInfo
- Publication number
- AU2004284461A1 AU2004284461A1 AU2004284461A AU2004284461A AU2004284461A1 AU 2004284461 A1 AU2004284461 A1 AU 2004284461A1 AU 2004284461 A AU2004284461 A AU 2004284461A AU 2004284461 A AU2004284461 A AU 2004284461A AU 2004284461 A1 AU2004284461 A1 AU 2004284461A1
- Authority
- AU
- Australia
- Prior art keywords
- plates
- tissue
- dimensional array
- array
- stack
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 70
- 239000000463 material Substances 0.000 claims description 50
- 238000003491 array Methods 0.000 claims description 38
- 239000000499 gel Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 23
- 210000001520 comb Anatomy 0.000 claims description 20
- 239000012188 paraffin wax Substances 0.000 claims description 11
- -1 antibodies Substances 0.000 claims description 10
- 238000002844 melting Methods 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 230000008018 melting Effects 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 239000004593 Epoxy Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 3
- 230000004888 barrier function Effects 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 2
- 108010038807 Oligopeptides Proteins 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims description 2
- 239000002157 polynucleotide Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 238000003466 welding Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 75
- 239000000523 sample Substances 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 20
- 238000002493 microarray Methods 0.000 description 17
- 239000011521 glass Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 229920003023 plastic Polymers 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 238000007639 printing Methods 0.000 description 9
- 238000005553 drilling Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000004377 microelectronic Methods 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 102000043276 Oncogene Human genes 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000012056 semi-solid material Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000009974 thixotropic effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009699 differential effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000239634 longleaf box Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003232 mucoadhesive effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 231100000622 toxicogenomics Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/128—Chemically defined matrices for immobilising, holding or storing living parts, e.g. alginate gels; Chemically altering living parts, e.g. by cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00545—Colours
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00644—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being present in discrete locations, e.g. gel pads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00664—Three-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00673—Slice arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00677—Ex-situ synthesis followed by deposition on the substrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/0074—Biological products
- B01J2219/00743—Cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/00745—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/12—Specific details about manufacturing devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0874—Three dimensional network
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Cell Biology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Description
WO 2005/040348 PCT/US2004/035209 METHOD FOR TWO- AND THREE-DIMENSIONAL MICROASSEMBLY OF PATTERNS AND STRUCTURES FIELD OF THE INVENTION The present invention relates to a method for constructing two-dimensional (2D) and three-dimensional (3D) patterns and structures. The present invention more particularly relates to preparation of materials for large scale parallel analysis of solid or solidified samples, such as tissue samples. The 2D and 3D microassembled structures prepared according to the present invention have application to other broad fields including pattern printing, tissue engineering, microfluidics, microelectronics, and microconstruction. BACKGROUND OF THE INVENTION A method for generating high density arrays of microscopic tissue samples on glass slides has been described and widely adopted (Kononen et al., (1998); Bubendorf et al., (1999); Schraml et al., (1999); Bubendorf et al., (2001a); Bubendorf et al., (2001b); U.S. Patent No. 6,103,518 to Leighton et al.). However, current methodology to display high density arrays of tissue samples on glass slides for analysis (e.g., microscopy, histochemistry, immunohistochemistry, fluorescent in situ hybridization, etc.) is limited to densities of less than 100 features/cm 2 . Valuable space is wasted on the array by the residual space between circular features. The current requirement of space in the array is dictated by the cylindrical cores generated by current technology of drilling cores in the tissue or in the medium (e.g., plastic, paraffin, etc.). Kononen and colleagues have described parallel display of up to 1,000 small tissue or tumor samples of 0.6 mm in diameter on a single microscope slide (about 2 cm x 5 cm available surface) that can be processed simultaneously for direct microscopy or scanning or microscopy or scanning after immunohistochemical staining or other staining procedures (e.g., regular tissue staining with hematoxylin + eosin, fluorescence-based in situ mRNA or DNA analysis, etc.). The method of Kononen et al. combines innovative placement of tissue cores of up to 10 mm in WO 2005/040348 PCT/US2004/035209 -2 height into predrilled holes in a paraffin block to assemble a high density of sample cores lined up in parallel. Once a complete collection of tissue cores has been placed in the same tissue block, transverse sections are cut by a microtome, and the resulting 3-10ptm thick sections are transferred to glass slides and adhered or cross 5 linked to the coated glass. The resulting microarray of small tissue samples can be duplicated many times by cutting multiple sections. However, the method of Kononen et al. suffers from a number of limitations. Sample density is limited due to needed space between samples to maintain the integrity of the paraffin holding block. Currently, the maximal limit is 1,000 10 samples per slide (~100 tissue features/cm 2 ). The height of the tissue block is limited due to limitations in the height of each core (0.5 to 1 cm). This height restriction limits the number of theoretical sections to approximately 13,000 sections when cut at 3ptm thickness. This method also promotes inefficient use of samples. Because the method is based on drilling cores out of the primary sample, e.g., a 15 tumor specimen, there will be wasted sample material left between the drilling holes. Core drilling results in reduced quality of the remaining tissue sample, because the integrity of the original sample is broken by the core(s) that are removed (i.e., a "Swiss cheese" effect is produced). The method of Kononen et al. requires a certain structural rigidity of the 20 sample to work. Softer tissues or materials will be crushed when attempting to remove the core from the drill. Moreover, the method can be most readily used with paraffin-embedded tissue and less readily on frozen tissue or softer gelatinous tissues or material. Finally, although a core-drilling, semi-automated tissue arraying machine has recently been introduced (ATA-27 Automated Arrayer, Beecher 25 Instruments), the core-based semi-automated technology is limited to handling only a low number of specimens at a time, currently a maximum of twenty-six specimens due to the labor-intensive transfer of individual samples to the block. This method is also not readily fully automated due to the manual drilling of cores and placement of individual cores one by one into the predrilled holes. This problem is in part due 30 to the need for movement of the tissue core from sample to block at a central site, WO 2005/040348 PCT/US2004/035209 -3 with the very limited possibility of gathering and storing cores (samples) before assembly. The present invention overcomes many of these problems and increases the density of array elements that can be achieved. While the present method is 5 described in detail for tissue arrays, the method has widespread applications as discussed below. SUMMARY The present invention provides for a method of microassembling 2D and 3D 10 arrays comprising stacking and optionally bonding two or more plates of one or more sample materials to form a primary stack; forming a comb by slicing the primary stack perpendicularly to the plane of the two or more plates; 15 stacking and optionally bonding two or more combs to form a secondary stack; and slicing the secondary stack to form a 2D array. A 3D array is formed by stacking and optionally bonding two or more 2D arrays. 20 BRIEF DESCRIPTION OF THE FIGURES Figures lA-i1E are a diagrammatic representation of the steps of the method for creating 2D and 3D arrays. Figure 2 shows an exemplary 2D tissue array generated using the method of the present invention. 25 Figure 3 shows exemplary secondary stacks of tissue arrays for cutting into tertiary plates. Figure 4 demonstrates the use of 2D and 3D arrays for creating mosaic patterns for printing or for tissue engineering.
WO 2005/040348 PCT/US2004/035209 -4 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In general, terms in the present application are used consistent with the manner in which those terms are understood in the art. To aid in the understanding of the specification and claims, the following definitions are provided. 5 "Primary plate" or "plate" refer to a substantially flat portion or "slice" of material. The primary plate can comprise any number of materials, including tissue (e.g., plant and animal), plastic, polymers, metal, semi-conducting materials, glass, silica-based materials, semi-solid materials such as gels, solidified (e.g., frozen) solutions, suspensions, or colloids, etc., and combinations thereof. The selection of 10 the plate material is usually determined by the purpose of the array to be made therefrom. The primary plates may be generated by several alternative means, including slicing from a larger block, by deposition of material of interest onto a thin support substrate (e.g., plastic, mesh, paper), by embedding of material into thin polymer or gel sheets or slabs, or by derivation directly from sheet-like materials 15 (e.g., plant leaves). The thickness of a primary plate may be determined by the availability or scarcity of the plate material, and/or the intended purpose of the array. Thinner primary plate slices will produce smaller array features and increase the number of array features that will fit in a given area. The size (i.e., the area of the primary plate) is not intended to be limited in any way by the present invention. 20 "Primary stack" refers to a stack of two or more plates. When complex arrays are constructed with many array elements, the plates are preferably assembled into the primary stack in a predetermined order. "Comb" refers to a secondary plate generated by taking a "slice" of a primary stack. The secondary plate comprises lengths of usually rectangular portions of each 25 of the plates of the primary stack. Again, the thickness of the slice may be determined, inter alia, by the availability of materials and intended purpose of the array. "Secondary stack" refers to a stack of two or more combs. "Tertiary plate" or 2D array refers to a cross-sectioned portion of a 30 secondary stack (i.e., a "slice" taken perpendicularly to the length of the secondary stack) containing several or many array elements. Tertiary plates can be stacked to WO 2005/040348 PCT/US2004/035209 -5 form a 3D microstructure or array. The thickness of the tertiary plate may be selected based on, inter alia, material availability and/or the intended purpose, e.g., whether the tertiary plate is further stacked to form a 3D array. Plates and stacks may be "sliced" using any tools known in the art. Freehand 5 slicing can be performed using a razor blade or knife, or other tools (including automated tools) such as a microtome can be utilized for enhanced precision. Currently available methodology to display high density arrays of tissue samples on glass slides is limited to densities of less than 100 features/cm. Embodiments of the present invention utilize new methodology that does not rely on 10 drilling of cores and that uses a more practical and space-utilizing method. Embodiments of the present invention therefore provide significant advantages over current methodology. Embodiments of the present invention are not limited to high-density display of tissue samples on a substrate/surface, but can be adapted to high-density, 15 organized 2D display of a variety of samples or reagents (biological, synthetic, inorganic), such as plastics, plants, antibodies, metals, etc. For display of solutes or liquids, these reagents may be made into a solid or semi-solid for section cutting (e.g., by incorporation into a gel or polymer). Embodiments of the present invention can be used to generate high-density arrays of biomolecules such as nucleotides, 20 oligo- and polynucleotides, nucleic acids, amino acids, oligo- and polypeptides, plasmids, proteins, antibodies (Chin and Kong, (2002); Pollock (2002); Templin et al., (2002); Gracey and Cossins, (2003)), which are currently generally printed onto substrates using printing technologies such as pin-based spotting or ink-jet technology (Watson et al., (1998); Harris et al., (2000)). Additionally, arrays of 25 microorganisms such as bacteria and viruses can be created using embodiments of the present invention. In practice, display of macromolecules or microbes can be achieved by embedding the macromolecules or microbes in a gel or polymer so that a semi-solid or solid medium useful for slicing is formed that contains the composition of interest. Macromolecules may also be chemically bonded or 30 conjugated to the polymer or gel matrix to hinder loss, or bleeding, during subsequent manipulation. Chemical binding can include crosslinking that achieves WO 2005/040348 PCT/US2004/035209 -6 covalent attachment using a series of established chemistries known to those skilled in the art (See, e.g., Hermanson, (1996)), such as glutaraldehyde, fonnaldehyde, or N-hydroxysuccinimide esters. Chemical binding also includes non-covalent bonding, e.g., via biotin-streptavidin interaction (Bundy and Fenselau, (2001); Ruiz 5 Taylor et al., (2001)). When tissue is used to prepare 2D or 3D arrays, a variety of materials can be utilized. The tissues can be paraffin-embedded, quick-frozen, or freeze-dried. Other embedding matrixes known in the art, such as epoxies, waxes, gelatin, agar, polyethylene glycols, polyvinyl alcohols, celloidin, nitrocellulose, methyl and butyl 10 methacrylate resins, polymers, and the like, and combinations thereof, can be used as well as long as the tissue maintains a solid or semi-solid form in order to prepare the plates and stacks of the present method. Paraffin-embedded tissue may be used in a preferred embodiment. While physical separators may be used in some embodiments of the present 15 invention, these are not necessary for all applications. Even when semi-solid materials are used, other means of segregation can be utilized. For instance, self healing gels, with thixotropic properties,which spontaneously repair or reestablish themselves after cutting or shearing (e.g., gels made from iota-carrageenans (Bavarian et al., (1996); Parker and Tilly, (1994)), adhesive polymers (e.g., 20 polyethylene glycol), or hydrogels (Peppas and Sahlin, (1996); Sahlin and Peppas, (1997); Tang et al. (2003)), may be used for self-adhesion of gel plates containing different macromolecules without the need for additional bonding agent. For instance, one may place an electrical conducting gel next to a non-conducting gel to generate 2D or 3D electrical circuitry. Alternatively, plates of water-containing gels 25 or substances may be bonded by freezing, also without a specific physical separator. Even when solid materials are used, one may choose to use physical separators as discussed below to identify sample elements in the array. Furthermore, self-healing or self-adhesive gels containing one or more types of live cells may be used to construct 2D or 3D scaffolds to establish organ-like 30 structures. Alternatively, gels containing immobilized (e.g., chemically cross linked) antibodies or other binding molecules (e.g., integrins, adhesion molecules) WO 2005/040348 PCT/US2004/035209 -7 that bind or attract specific cell types may be used. After building a 2D or 3D structure from gel plates according to an embodiment of the invention, the gel can be dried (e.g., by lyophilization) to form a porous scaffold. Gels dried by lyophilization or other means are commonly referred to as xerogels (Nicoll et al., 5 (1997); Radin et al., (2002)). This porous scaffold, which contains a predetermined cellular attraction or binding pattern that will specify binding of cells in 2D or 3D, can be rehydrated and exposed to live cells, which will then form a structure as determined by the materials contained in the scaffold. The gel can comprise biodegradable material (e.g., collagen) and can be sterilized by radiation or chemical 10 means before the addition of live cells to ensure microbe-free growth. This approach can be used to generate functional organs and organ elements (e.g., hair follicles, hormone producing units, kidney elements). The basic methodology for 2D pattern construction used above can be adapted to 3D pattern construction or microconstruction by organized stacking of 15 sheets of 2D patterns. The ability to systematically build 3D microstructures can be useful for a variety of fields. Micromechanical devices can be assembled by the present methods. Building 2D or 3D networks of variable thickness using materials that are electrically conductive, semiconductive, or insulating or resisting may be useful for microelectronic devices. 2D electrical circuits can be made using a 20 printing technique. Specifying 3D patterns and microstructures of specific affinity for different cell types in a porous substrate may be useful for advanced 3D tissue engineering and 3D microarrangement of live cells. Building a 3D structure of microchannels is useful for the emerging field of microfluidics. Channels could be generated in the 25 3D structure by melting, dissolving, or enzymatically digesting elements of differential properties to create a microfluidic device or a tissue lattice. Thus, the present invention provides for a method of preparing a lattice comprising: - creating a 2D or 3D array by - stacking and optionally bonding two or more plates of one or more 30 sample materials to form a primary stack; WO 2005/040348 PCT/US2004/035209 - forming a comb by slicing the primary stack perpendicularly to the plane of the two or more plates; - stacking and optionally bonding two or more combs to form a secondary stack; 5 - slicing the secondary stack to form a 2D array; - optionally stacking and optionally bonding two or more 2D arrays to form a 3D array; and - melting, dissolving, or enzymatically digesting some elements of the array to create a lattice. 10 Another embodiment of the present invention provides for a method of preparing a microfluidic device comprising: - creating a 2D or 3D array by - stacking and optionally bonding two or more plates of one or more sample materials to form a primary stack; 15 - forming a comb by slicing the primary stack perpendicularly to the plane of the two or more plates; - stacking and optionally bonding two or more combs to form a secondary stack; - slicing the secondary stack to form a 2D array; 20 - optionally stacking and optionally bonding two or more 2D arrays to form a 3D array; and - melting, dissolving, or enzymatically digesting some elements of the array to create gaps or channels in the 2D or 3D array to prepare a microfluidic device. High-density arraying of different soluble samples/reagents, including 25 oligonucleotides, plasmids, proteins, etc. onto a solid surface (e.g., glass) is typically achieved by ink-jet technology, or pattern or pin-spot printing. The present method is expected to be useful for depositing these types of 2D arrays without the use of traditional printing equipment. Instead, soluble reagents are made solid or semi solid by freezing, gelling, or otherwise absorbed and embedded onto a substrate 30 from which slices are cut, stacked, and processed as described for the general approach and transferred to the solid surface by sectioning. A distinct benefit of the WO 2005/040348 PCT/US2004/035209 -9 present methodology is that sample arrays can be stored as blocks and arrays can be cut and "printed" at any time when needed. Certain biological reagents are not stable in liquid form, but are much more stable when dried (e.g., lyophilized), fixed, frozen, or precipitated. 5 Embodiments of the present invention can approach a maximum of about 10,000 tissue features of a size of about 0.1 mm 2 on about 2 cm x about 5 cm area glass slide (or -1,000 tissue features/cm 2 ), has no immediate height limitation of individual samples (about 100 cm could be possible, corresponding to about 200,000 approximately 5pm thick sections), effectively uses the primary sample 10 (theoretically, no waste), does not reduce the quality of the leftover primary sample (if not fully used), and works on rigid as well as softer, gelatinous, and frozen tissue. Because embodiments of the present invention do not rely on drilling of cores, but simple generation of slices, individual samples can be precut, and semiautomated or automated assembly can take place by use of a device. Thus, embodiments of the 15 present invention are less labor-intensive and requires less skill than currently available methodology in the art. Finally, embodiments of the present invention are not limited to 2D array building on a substrate, but will allow building/printing of 2D micropatterns that could be useful for broad fields, including microfabrication, microfluidics, electronics, and tissue engineering. 20 The general procedure to produce 2D arrays involves stacking primary plates (sections) of sample materials into primary stacks, with subsequent generation of secondary sections (combs) by perpendicular cross-sectional sectioning of primary stacks, followed by bonding of combs into secondary stacks. For 2D arrays/patterns, tertiary sections are generated by cross-sectioning perpendicular to 25 the teeth of the secondary stack of combs, and sections may then be transferred to a support substrate, e.g., glass slide. This procedure, and exemplary arrays resulting therefrom, is demonstrated in Figures 1-3. Plates, stacks, combs, and arrays may be bonded together. The bonding material can be, for instance, glue (e.g., acrylate), paraffin, 2-sided adhesive, 30 epoxies, waxes, polymers such as methyl and butyl acrylate resins and polyvinyl alcohol, gelatin, polyethylene glycol, and the like, and combinations thereof. The WO 2005/040348 PCT/US2004/035209 - 10 plates, stacks, combs, or arrays may be bonded by welding and/or melting. However, one skilled in the art will recognize that it is not essential that the plates or stacks are physically bonded together. For instance, it is possible to use embedding in a firm medium (e.g., wax, polymer, etc.) or to use a frame that fits around the 5 plates or stacks and serves to hold them together. The final array can also be held intact by bonding the array to a substrate such as a glass slide. One of the benefits of the present invention is that sample density can be increased over other known methods. However, it is also possible to add space between samples plates, e.g., a paraffin blank. 10 Another embodiment of the invention is that by interlacing color-coded or structurally coded "leaves" between the plates in the stacks, microarrays can be generated with built-in orientation so that every feature is framed by a position unique combination of color/structure. For instance, the plates and stacks can be subdivided into quadrants to delineate samples. One can insert a unique 15 combination of leaves around a particular sample element. This in turn can be used for automated readers to assign values correctly to individual samples, or for the manual analyst to record observations correctly for each of the individual samples. The leaves or physical barriers between array elements, can comprise a wide variety of materials including adhesive, plastics, metal, etc. 20 By using a variety of labeled bonding materials or physical barriers between array elements, one can enhance the invention by providing unique identifiers around each feature. This is especially useful in a 2D array so that one can identify a sample in the microscope or a microphotograph based on the coding of the four surrounding sides. For simplicity, different colored or patterned two-sided adhesive 25 or glue can be used for each primary plate that is bonded together. Likewise, unique-colored glue may also be used for bonding each of the secondary plates. Varied colored or patterned plastics or other solid dividers may also be added. The dividers may also contain information identifying the sample element in the form of a magnetic strip. As a result, each feature in the final array will be framed by a 30 unique set of four colors that will only occur once in the array provided enough WO 2005/040348 PCT/US2004/035209 - 11 unique colors are used. In addition to color, texture can be modified by adding, e.g., different grainy microparticles or fibers to the bonding material. The organized display of multiple samples for analysis in a microarray arrangement as described in the Examples below is one use of an embodiment of the 5 invention. The invention can also be presented as a method to specify predetermined patterns or arrangement of samples in two and three dimensions. In the example above with a tissue microarray, a high-density 2D array of tissue squares arranged as quilts or mosaics on a solid support or substrate (e.g., a glass plate). 10 While it is preferable that the elements of the array are square or otherwise rectangular (in order to maximize space and minimize waste of material), it is understood that as long as the tissues are maintained in a defined space, various embodiments can be envisioned. It may be desirable to have larger portions of the arrays comprise a particular material. 15 After generating a 2D mosaic pattern, one can extend the array by stacking multiple 2D patterns on top of each other to form 3D patterns. Because the sections can be kept very thin, high resolution, small-scale patterns or microstructures can be achieved. Figure 4 illustrates generation of a 3D branching structure using the stacking of eight 2D patterns. 20 Further, the present invention can be used to fashion a 3D scaffold. Scaffold material plates can be alternated with other plates which may be dissolved or melted upon the generation of the secondary stack or tertiary plate. For example, plates of paraffin can be alternated with plates of a higher-melting material. Additional materials may be added into the remaining spaces or cavities. For tissue 25 engineering applications, e.g., one can seed certain cell types into the spaces. The present technology can be used to print or place antibodies to attract certain types of cells to certain regions of the scaffold. Once 2D or 3D arrays have been generated, they may be affixed to a substrate or solid support, such as glass or silica plates, plastics, metal, semi 30 conducting materials, solid porous or non-porous surfaces, polysaccharide-based WO 2005/040348 PCT/US2004/035209 - 12 surfaces, nitrocellulose paper, fabric, and the like, or combinations thereof. For example, the arrays may be adhered to or cross-linked to the solid support. EXAMPLES 5 In addition to the specific materials and methods referred to below, one of skill in the art is directed to the references cited in this application as well as the several Current Protocol guides, which are continuously updated, widely available and published by John Wiley and Sons (New York). In the life sciences, Current Protocols publishes comprehensive manuals in Molecular Biology, Immunology, 10 Human Genetics, Protein Science, Cytometry, Neuroscience, Pharmacology, Cell Biology, Toxicology, and Nucleic Acid Chemistry. Additional sources, including general references for microfluidics, tissue engineering, and microelectronics, are known to one of skill in the art. 15 EXAMPLE 1 - General procedure for constructing a tissue microarray. In the case of tissue microarray construction, the procedure involves the following steps (an example of eight different tissues from eight individuals to be represented as a display of a total of 64 sample array is used): From a block of processed tissue (typically formalin-fixed, paraffin 20 embedded tissue as is routinely used in pathology laboratories), a primary section or plate is cut at the desired thickness. (Figure 1A). For instance, a plate of the dimension 1 cm by 1 cm at a thickness of 0.1 cm (1 nun). The selected thickness will define the width of the final feature or sample as the sample is represented in the array. The technology allows one to easily vary the size of the final features by 25 using plates of different thickness. This process is repeated on additional samples to generate a first or primary stack of tissue plates. For instance, a total of 8 samples representing kidney, liver, muscle, heart, stomach, pancreas, spleen, and thyroid gland are processed. The tissue plates of this primary stack are bonded together so that they form 30 one inseparable unit of plates that are stacked in a predetermined order. (Figure 1B). The bonding material of preference for tissue stacks is acrylate (e.g., WO 2005/040348 PCT/US2004/035209 - 13 superglue, or one of the derivative acrylates). In practice, a thin layer of acrylate is added to the top of the first plate, then the second plate is laid on top and weighted down for a few minutes. The process is repeated for each plate. It is possible to save time by adding acrylate to all plates at the same time, and then stacking them 5 and weighting the plates down all at once. This process can also be automated. Another seven primary stacks are produced from the same tissues from different individuals. The order of the tissues are recorded so that the position of each sample is kept track of. For simplicity, each stack may be composed of the eight tissues arranged in the same order, but that is not a requirement. 10 From each bonded stack of tissues, new secondary plates are cut perpendicularly to the plane of the plates. This will result in a secondary plate that resembles a comb, where each tooth of the comb represents each of the eight tissues. (Figure 1C). In the simplest case, the thickness of the cut is maintained at 1 mm (0.1 cm). The thickness of the comb will define the height of the final sample 15 feature as will become apparent. If the thickness of the comb is cut at the same thickness of the primary plates, this will result in square features. However, the method permits variation of the thickness of the comb section, so that rectangular features are possible. This benefit is currently not possible with the existing circular, core-based methodology for tissue array construction, and can be useful for 20 effective display on monitors, film, or print, which typically have aspect ratios different than 1:1 (e.g., 8 x 10 inch prints can be achieved without image distortion). Eight combs (secondary plates) are then stacked and bonded in a predetermined order to form a secondary stack. (Figure 1D). This secondary stack can be visualized literally as eight hair combs glued together so that the teeth are 25 oriented in the same direction. The secondary stack is embedded in paraffin so that the teeth of the combs are oriented up, available for sectioning with a histological microtome. Using the microtome, thin sections are cut in a plane through all the teeth of the combs, resulting in a tertiary plate that contains 8 x 8 features, each representing 30 one of the 64 original tissue samples. (Figure 1E). This thin section may be placed on a glass slide using traditional histological techniques, and a microarray of 64 WO 2005/040348 PCT/US2004/035209 - 14 tissue samples is produced. This can then be analyzed by traditional immunohistological staining, immunohistochemistry, in situ hybridization, etc. EXAMPLE 2 - Generation of a 2D tissue array. 5 Several paraffin-embedded tissues were sliced by hand to make primary plates of tissue. These tissue plates were bonded together (as a primary stack) with acrylate to keep the individual paraffin-embedded tissue features together. Several primary stacks were sliced by hand across several stacks to create several secondary plates, or combs. Several of the combs were bonded together with acrylate to create 10 a secondary stack. The secondary stack was then sliced using a microtome to create a sample 2D array (or tertiary plate) as shown in Figure 2 that is 10 ym thick with feature sizes of between 0.25 mnm and 1 mn-. The primary and secondary stacks of the tissue array presented in Figure 2 were prepared freehand (rather than by precise slicing with a microtome), hence the uneven-sized features and the angled section 15 lines. Figure 3 shows multiple secondary stacks (such as those used to slice the tertiary plate shown in Figure 2). The various tissue elements used result in a checkerboard appearance of the secondary stacks. The sizes of the cube-shaped secondary stacks in Figure 3 are approximately 1 cm 3 per cube. 20 EXAMPLE 3 - Applications of 2D and 3D array for large-scale parallel analysis. Diagnostic and screening arrays. Microarrays are useful for two types of analyses: 1) measuring many analytes (e.g., mRNA, proteins) in one sample, by contacting a sample with a large 25 number of features that represent individual analytes in the microarray, and 2) analyzing many samples displayed in a microarray at once by direct physical, chemical, or image analysis. The present invention is useful for both types of parallel analyses. Solutions of nucleic acids of interest, e.g., oncogenes, etc., may be frozen or incorporated into gels to prepare arrays for diagnostic applications and 30 high-throughput screening. For example, one can construct a 2D array of oligonucleotides of various oncogenes in order to screen individual tumors for WO 2005/040348 PCT/US2004/035209 - 15 particular genotypes or gene expression profiles. Likewise, arrays of protein targets can be used to screen for compounds that bind to a particular target or inhibit/activate an enzyme. Alternatively, arrays could contain both control and neoplastic (or otherwise diseased or abnormal) tissue or sample extract, blood, or 5 liquid that has been immobilized in semi-solid or solid form and displayed in parallel using an embodiment of the present invention. The 2D arrays allow large scale parallel analysis of solid, solidified, or semi-solid samples which is useful, inter alia, in high-throughput screening or large-scale diagnostic clinical applications. 10 Microfluidics. Microfluidics involves the use of small disposable devices for the handling of biological samples and performing controlled in vitro experiments. For example, microfluidics encompasses the microscopic study of compounds on small numbers 15 of cells. This study is facilitated by the use of microfluidic devices that allow control of the flow of a compound coming into contact with a cell, relying on small volumes to transport both cells and compounds. WO 98/52691 describes sample microfluidic devices. Microfluidic devices can be made using the 2D and 3D arrays created by the present method. To form channels in the microfluidic devices, 20 meltable, dissolvable, or enzymatically digestible material can be used or spaces can be intentionally left in the tertiary plates by using a solid supports that line the sides of a particular array element but that are hollow on the inside. Such an approach may involve removing elements (e.g., by melting or digestion) at the tertiary plate stage, and coating the surface of the tertiary stack (e.g., with glue or cross-linker) 25 before assembly into the 3D tertiary stack. Furthermore, once a 3D block with tunnels is obtained, one can further coat the tunnel surface with, e.g., silicon, thin plastic, or chemical reagents. For example, two types of material can be used as the initial plates to form the primary stack. One material could be a plastic and the other material could be paraffin with a much lower melting point. Once the tertiary plates 30 are stacked to forn a 3D array, the array may be subjected to heat to melt the paraffin, leaving the plastic intact. Thus, in such a manner, one can form a 3D array WO 2005/040348 PCT/US2004/035209 - 16 with channels for use in microfluidics. Likewise, microchannels may be useful for the molding of small parts. Tissue Engineering 5 The ability to generate 3D microstructures has important applications in biology. Tissue engineering involves fabricating new functional tissue using living cells and a matrix or scaffolding which can be natural, synthetic or combinations of both. One can generate such matrices or scaffolding using 3D arrays prepared according to an embodiment of the present invention. While some progress has 10 been made in generating structurally relatively simple organs such as bone, hairless skin, and bladder, elements or organs with a high degree of microscopic complexity can be generated using an embodiment of the present invention. Tissue engineering of simple trabecular bone typically involves seeding of bone-producing cells, osteoblasts, into a porous, homogenous scaffold without 3D complexity (Borden et 15 al., (2002); Ciapetti et al. (2003); Lu et al. (2003)). U.S. Patent No. 6,576,019 describes a method for bladder reconstruction. Similarly to the method disclosed in the '019 patent, 2D and 3D matrices of embodiments of the present invention may be used to reconstruct a bladder. Uroepithelial cells can be deposited in one portion of the array and smooth muscle cells can be deposited in a different portion. These 20 matrices can be utilized to provide cells to the desired location in the body in order to accurately guide new tissue development. For instance, using Figure 4 as an example, the black features could represent gel material containing one cell type, e.g., epithelial cells, while the white features could represent gel material containing another cell type, e.g., supporting fibroblast cells. Complex organs or organ 25 elements can be constructed that contain branching cellular patterns at a micrometer scale, for instance, secretory organs like pancreas or breasts. Biodegradable polymers or substances can be used to construct such arrays. For instance, improved tissue engineering of a) insulin-producing Langerhans islands for patients with Type I diabetes, b) functional kidney elements, or c) skin with hair follicles are just 30 several of numerous possibilities. Hair and skin cells can be made into an array in an alternating pattern.
WO 2005/040348 PCT/US2004/035209 - 17 Pattern Printing Once secondary stacks or tertiary plates have been created, they can be used to produce pattern prints which can be affixed to a desired surface or fabric. In 5 addition to generating high-density arrays of samples for analysis, one can generate patterns by specifying which individual feature will be localized in a given space (or coordinate) by selecting the correct location of a material in the primary and secondary stack. In other words, one may use this technology to print or specify patterns on a surface, by specifying the location of contrasting elements. A simple 10 checkered pattern can be produced by use of white and black starting material as alternating layers in a primary stack. More advanced patterns could involve multiple colors, or distinct materials that would form 2D patterns of any type. Each feature would represent a square pixel in image terminology. This could be expanded to 3D by overlaying 2D patterns using materials of variable translucency. 15 This could be useful for generation of unique identifiers that can be recognized by appropriate readers. While the invention has been described and illustrated above by reference to various specific materials, procedures and examples, it is understood that the 20 invention is not restricted to the particular materials, combinations of materials, and procedures selected for that purpose. Numerous variations of such details can be implied and will be appreciated by those skilled in the art. REFERENCES 25 Baravian, C., D. Quemada and A. Parker (1996). "Modelling thixotropy using a novel structural kinectics approach: basis and application to a solution of iota carrageenan." Journal of Texture Studies, 27, 371-390. Borden, M., M. Attawia, et al. (2002). "The sintered microsphere matrix for 30 bone tissue enginerring: in vitro osteoconductivity studies." JBiomed Mater Res 61(3): 421-9.
WO 2005/040348 PCT/US2004/035209 - 18 Bubendorf, L., B. Grilli, et al. (2001a). "Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings." Am J Clin Pathol 116(1): 79-86. Bubendorf, L., J. Kononen, et al. (1999). "Survey of gene amplifications 5 during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays." Cancer Res 59(4): 803-6. Bubendorf, L., A. Nocito, et al. (2001b). "Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies." J Pathol 195(1): 72-9. 10 Bundy, J. L. and C. Fenselau (2001). "Lectin and carbohydrate affinity capture surfaces for mass spectrometric analysis of microorganisms." Anal Chem 73(4): 751-7. Chin, K.V. and A. N. Kong (2002). "Application of DNA microarrays in pharmacogenomics and toxicogenomics." Pharm Res 19(12): 1773-8. 15 Ciapetti, G., L. Ambrosio, et al. (2003) "Osteoblast growth and function in porous poly varepsilon-caprolactone matrices for bone repair: a preliminary study." Biomaterials 24(21): 3815-24. Gracey, A. Y. and A.R. Cossins (2003). "Application of microarray technology in enviromental and comparative physiology." Annu Rev Physiol 65: 20 231-59. Harris, T.M., A. Massimi, et al. (2000). "Injecting new ideas into microarray printing." Nat Biotechnol 18(4): 384-5. Hermanson, G.T. (1996). Bioconjugate techniques. San Diego, Academic Press. 25 Kononen, J., L. Bubendorf, et al. (1998). "Tissue microarrays for high throughput molecular profiling of tumor specimens." Nat Med 4(7): 844-7. Lu, H.H., S. F. El-Amin, et al. (2003) "Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human 30 osteoblast-like cells in vitro." J. Biomed Mater Res 64A(3): 465-74.
WO 2005/040348 PCT/US2004/035209 - 19 Nicoll, S. B., S. Radin, et al. (1997). "In vitro release kinetics of biologically active transforming growth factor-beta 1 from a novel porous glass carrier." Biomaterials 18(12): 853-9. Parker, A. and G. Tilly, "Thixotropic carrageenan gels and dairy desserts." 5 In: "Gums and Stabilisers for the Food Industry 7", pp. 393-401. Editors Phillips G. 0., Williams, P. A. and Wedlock D. J., Oxford University Press (1994). Peppas, N. A. and J. J. Sahlin (1996). "Hydrogels as mucoadhesive and bioadhesive materials: a review." Biomaterials 17(16): 1553-61. Pollock, J. D. (2002). "Gene expression profiling: methodological 10 challenges, results, and prospects for addiction research." Chen Phys Lipids 121(1 2): 241-56. Radin, S., S. Falaize, et al. (2002). "In vitro bioactivity and degradation behavior of silica xerogels intended as conrolled release materials." Bionaterials 23(15): 3113-22. 15 Ruiz-Taylor, L. A., T. L. Martin, et al. (2001). "Monolayers of derivatized poly(L-lysine)-grafted poly(ethylene glycol) on metal oxides as a class of biomolecular interfaces." Proc Natl Acad Sci USA 98(3): 852-7. Sahlin, J. J. and N. A. Peppas (1997). "Enhanced hydrogel adhesion by polymer interdiffusin: use of linear poly(ethylene glycol) as an adhesion promoter." 20 J Biomater Sci Polym Ed 8(6): 421-36. Schraml, P., J. Kononen, et al. (1999). "Tissue microarrays for gene amplification surveys in many different tumor types." Clin Cancer Res 5(8): 1996 75. Tang, Y., E. C. Tehan, et al. (2003). "Sol-gel-derived sensor materials that 25 yield linear calibration plots, high sensitivity, and long-term stability." Anal Chem 75(10): 2407-13. Templin, M. F., D. Stoll, et al. (2002). "Protein microarray teclmology." Trends Biotechnol 20(4): 160-6. Watson, A., A. Mazumder, et al. (1998). "Technology for microarray 30 analysis of gene expression." Curr Opin Biotechnol 9(6): 609-14.
WO 2005/040348 PCT/US2004/035209 - 20 All references cited above are incorporated in their entity herein by reference for all purposes.
Claims (20)
1. A method of preparing a two-dimensional array comprising: - stacking and optionally bonding two or more plates of one or more sample materials to form a primary stack; 5 - forming a comb by slicing the primary stack perpendicularly to the plane of the two or more plates; - stacking and optionally bonding two or more combs to form a secondary stack; and - slicing the secondary stack to form a two-dimensional array. 10
2. A method of preparing a three dimensional array comprising: - stacking and optionally bonding two or more plates of one or more sample materials to form a primary stack; - forming a comb by slicing the primary stack perpendicularly to the 15 plane of the two or more plates; - stacking and optionally bonding two or more combs to form a secondary stack; - slicing the secondary stack to form a two-dimensional array; and - stacking and optionally bonding two or more two-dimensional 20 arrays to form a three-dimensional array.
3. The method of claim 1 or 2, wherein the plates and/or combs and/or secondary stacks are separated by a physical barrier. 25
4. The method of claim 1 or 2, wherein the one or more sample materials comprise tissue.
5. The method of claim 4, wherein the tissue is paraffin-embedded tissue, quick-frozen tissue, or freeze-dried tissue. 30 WO 2005/040348 PCT/US2004/035209 - 22
6. The method of claim 1 or 2, further comprising affixing the two- or three-dimensional array to a solid support.
7. The method of claim 6, wherein the two- or three-dimensional array 5 is adhered or cross-linked to the solid support.
8. The method of claim 1 or 2, wherein elements of the two- or three dimensional array are identified by position-specific markers. 10
9. The method of claim 8, wherein the position-specific markers comprise colored or patterned adhesive.
10. The method of claim 1 or 2, wherein the two or more plates and/or two or more combs are bonded to each other. 15
11. The method of claim 2, wherein the two or more two-dimensional arrays are bonded to each other.
12. The method of claim 10 or 11, wherein the two or more plates 20 and/or two or more combs and/or the two or more two-dimensional arrays are bonded to each other with acrylate, paraffin or other waxes, two-sided adhesive, epoxy, polymers, gelatin, polyethylene glycol, welding, melting, or the like, or a combination thereof 25
13. The method of claim 1 or 2, wherein the two more plates comprise an electrical conducting plate and a non-electrical conducting plate.
14. The method of claim 13, wherein the electrical conducting plate and the non-electrical conducting plate comprise gels. 30 WO 2005/040348 PCT/US2004/035209 - 23
15. The method of claim 1 or 2, wherein the two or more plates comprise an electrically conducting plate, a semi-conducting plate, and/or an insulating or resistor plate. 5
16. The method of claim 1 or 2, wherein the plates comprise nucleotides, oligonucleotides, polynucleotides, amino acids, oligopeptides, polypeptides, antibodies, plasmids, and/or microorganisms.
17. A two-dimensional array made by the method of claim 1. 10
18. A three-dimensional array made by the method of claim 2.
19. A method of preparing a tissue lattice comprising: - creating a two- or three-dimensional array according to claim 1 or 15 2; - melting, dissolving, or enzymatically digesting some elements of the array to create a tissue lattice.
20. A method of preparing a microfluidic device comprising: 20 - creating a two- or three-dimensional array according to claim 1 or 2; - melting, dissolving, or enzymatically digesting some elements of the array to create gaps or channels in the two- or three-dimensional array to prepare a microfluidic device.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51319703P | 2003-10-23 | 2003-10-23 | |
| US60/513,197 | 2003-10-23 | ||
| PCT/US2004/035209 WO2005040348A2 (en) | 2003-10-23 | 2004-10-22 | Method for two- and three-dimensional microassembly of patterns and structures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2004284461A1 true AU2004284461A1 (en) | 2005-05-06 |
Family
ID=34520077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004284461A Abandoned AU2004284461A1 (en) | 2003-10-23 | 2004-10-22 | Method for two- and three-dimensional microassembly of patterns and structures |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8349584B2 (en) |
| EP (1) | EP1681921A4 (en) |
| AU (1) | AU2004284461A1 (en) |
| CA (1) | CA2543782A1 (en) |
| WO (1) | WO2005040348A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004284461A1 (en) | 2003-10-23 | 2005-05-06 | Georgetown University | Method for two- and three-dimensional microassembly of patterns and structures |
| DE102006058730A1 (en) * | 2006-12-13 | 2008-06-19 | Dot Gmbh | Modular three-dimensional cell culture carrier useful in biological and medical applications, comprises a compound of stacked material layers, which are perforated as non-planar single layers |
| US8748091B2 (en) * | 2009-12-18 | 2014-06-10 | The Board Of Trustees Of The University Of Illinois | Characterizing stretched polynucleotides in a synthetic nanopassage |
| GB201202737D0 (en) * | 2012-02-17 | 2012-04-04 | Univ The Glasgow | Apparatus and methods for the preparation of reaction vessels |
| DE102012108508A1 (en) * | 2012-09-12 | 2014-03-13 | Carl Zeiss Ag | Method for treating sample e.g. biological specimen, involves patterning embedding material on sample holder and/or on embedding plate by using structures |
| CA2894750C (en) | 2013-02-22 | 2021-12-14 | Allosource | Cartilage mosaic compositions and methods |
| WO2014151939A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Perforated osteochondral allograft compositions |
| JP6908258B2 (en) * | 2016-02-09 | 2021-07-21 | 国立大学法人 長崎大学 | Ultra-dense tissue array |
| CN105749994B (en) * | 2016-04-23 | 2017-12-15 | 北京化工大学 | A kind of three-dimensional microflow control chip preparation method of plural layers fitting |
| JP7134586B2 (en) * | 2018-10-13 | 2022-09-12 | プーマ エス イー | clothing |
| US11460410B2 (en) | 2019-04-08 | 2022-10-04 | Puma SE | Bioindicator component applied to an article |
| US11603247B2 (en) | 2019-04-08 | 2023-03-14 | Puma SE | Biodegradable packaging |
| CN113394113B (en) * | 2021-05-17 | 2023-04-18 | 北京师范大学 | Transfer method and device for preparing low-dimensional material stacking structure |
| CN114547853B (en) * | 2022-01-12 | 2025-02-18 | 大连理工大学 | Design method and application of a three-dimensional porous inclined array structure for directional liquid transport |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684609A (en) * | 1981-06-15 | 1987-08-04 | Vector Laboratories, Inc. | Method and substance for the enhanced labelling of cellular material |
| US4497792A (en) * | 1981-12-18 | 1985-02-05 | Sherwood Medical Company | Specimen embedding composition |
| ATE33717T1 (en) * | 1983-02-25 | 1988-05-15 | Winfried Dr Med Stoecker | METHODS AND DEVICES FOR INVESTIGATIONS ON IMMOBILIZED BIOLOGICAL MATERIAL. |
| US5597692A (en) * | 1984-04-05 | 1997-01-28 | Howard Florey Institute Of Experimental Physiology And Medicine | Hybridization histochemistry method for determining the presence and location in animal or plant tissue of RNA |
| US4820504A (en) * | 1986-02-12 | 1989-04-11 | City Of Hope | Multi-specimen tissue blocks and slides |
| GB2189596B (en) * | 1986-04-16 | 1990-08-01 | Pa Consulting Services | Methods of and apparatus for preparing tissue specimens |
| US4752347A (en) * | 1986-10-03 | 1988-06-21 | Rada David C | Apparatus for preparing tissue sections |
| US4695339A (en) * | 1986-10-03 | 1987-09-22 | Rada David C | Method for preparing tissue sections |
| US4946669A (en) * | 1987-10-09 | 1990-08-07 | Siegfried Barry A | Histological fixatives |
| US4914022A (en) * | 1987-10-21 | 1990-04-03 | Amc Cancer Research Center | Method for preparing multiple tissue samples for microscopic investigation and testing |
| GB8813628D0 (en) * | 1988-06-09 | 1988-07-13 | Shandon Southern Prod | Immunostaining |
| US5002377A (en) * | 1988-07-07 | 1991-03-26 | City Of Hope | Multi-specimen slides for immunohistologic procedures |
| US5252487A (en) * | 1989-05-19 | 1993-10-12 | Cell Analysis Systems, Inc. | Method and apparatus for determining the amount of oncogene protein product in a cell sample |
| US5156019A (en) * | 1990-11-19 | 1992-10-20 | Mccormick James B | Frozen tissue sectioning apparatus and method |
| US5244787A (en) * | 1991-01-31 | 1993-09-14 | Biogenex Laboratories | Antigen retrieval in formalin-fixed tissues using microwave energy |
| US5784162A (en) * | 1993-08-18 | 1998-07-21 | Applied Spectral Imaging Ltd. | Spectral bio-imaging methods for biological research, medical diagnostics and therapy |
| US5281521A (en) * | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US5290706A (en) * | 1992-11-10 | 1994-03-01 | Camiener Gerald W | Visualization system for retrieval, identification, and positioning of biological samples for subsequent microscopic examination |
| US5514378A (en) * | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5487975A (en) * | 1993-11-15 | 1996-01-30 | Ventana Medical Systems, Inc. | Biotin/avidin formulation |
| US5432056A (en) * | 1993-11-15 | 1995-07-11 | Ventana Medical Systems, Inc. | Bisulfite-based tissue fixative |
| US5411885A (en) * | 1993-12-17 | 1995-05-02 | New York Blood Center, Inc. | Methods for tissue embedding and tissue culturing |
| US5431952A (en) * | 1994-02-28 | 1995-07-11 | Board Of Trustees Operating Michigan State University | Method for preservation of biological tissue |
| US5427742A (en) * | 1994-04-26 | 1995-06-27 | Holland; Wayne | Tissue processing cassette |
| US5452584A (en) * | 1994-07-13 | 1995-09-26 | Duke University | Method of freezing biological tissue specimens with opti-cryo-fluid |
| US5550033A (en) * | 1994-09-26 | 1996-08-27 | Krumdieck; Carlos | Mold plunger and method for embedding tissue samples |
| US5614376A (en) * | 1994-10-20 | 1997-03-25 | Dicin Resources, Inc. | Method for facilitating tissue slide preparation |
| SE9404166D0 (en) * | 1994-11-30 | 1994-11-30 | Pharmacia Biotech Ab | Multifunctional surfaces |
| US5750340A (en) * | 1995-04-07 | 1998-05-12 | University Of New Mexico | In situ hybridization solution and process |
| US5700656A (en) * | 1995-05-25 | 1997-12-23 | Pig Research Institute, Taiwan | Silver stain for collagen matrix from paraffin embedded tissue |
| US5888733A (en) * | 1995-11-16 | 1999-03-30 | Dako A/S | In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples |
| US5665398A (en) * | 1995-11-20 | 1997-09-09 | Mccormick; James B. | Apparatus for embedding tissue samples |
| US5817032A (en) * | 1996-05-14 | 1998-10-06 | Biopath Automation Llc. | Means and method for harvesting and handling tissue samples for biopsy analysis |
| US5776298A (en) * | 1996-07-26 | 1998-07-07 | Franks; James W. | Tissue preparation apparatus and method |
| WO1998052691A1 (en) | 1997-05-16 | 1998-11-26 | Alberta Research Council | Microfluidic system and methods of use |
| US5983991A (en) * | 1997-06-30 | 1999-11-16 | Franks; James W. | Tissue chuck |
| ATE248615T1 (en) * | 1997-10-31 | 2003-09-15 | Childrens Medical Center | BLADDER RECONSTRUCTION |
| US6699710B1 (en) * | 1998-02-25 | 2004-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Tumor tissue microarrays for rapid molecular profiling |
| US6022700A (en) * | 1998-03-12 | 2000-02-08 | Intelligent Imaging Innovations, Inc. | High throughput biological sample preparation device and methods for use thereof |
| CA2347002A1 (en) * | 1998-10-21 | 2000-04-27 | Steven Jay Smith | Protein quantitation with cell imaging densitometry |
| US6103518A (en) * | 1999-03-05 | 2000-08-15 | Beecher Instruments | Instrument for constructing tissue arrays |
| US6716632B1 (en) * | 1999-08-02 | 2004-04-06 | Gordon L. Dorn | System for stabilizing samples |
| AU2001280833A1 (en) * | 2000-07-28 | 2002-02-13 | Large Scale Proteomics Corporation | Microarrays and their manufacture by slicing |
| US6716629B2 (en) * | 2000-10-10 | 2004-04-06 | Biotrove, Inc. | Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| AU2002239775A1 (en) * | 2000-10-19 | 2002-06-03 | Virtual Arrays, Inc. | Chemical-library composition and method |
| WO2003050509A1 (en) * | 2000-11-30 | 2003-06-19 | Instrumedics Inc. | A method for creating a frozen tissue array |
| JP2004537035A (en) * | 2001-01-02 | 2004-12-09 | スパチル・テクノロジーズ・ピーティワイ・リミテッド | Method and apparatus for preparing a tissue sample for histological examination and pathological examination |
| US6536219B2 (en) * | 2001-05-03 | 2003-03-25 | Steven Peters | Apparatus and method for precision cryoembedding of tissue samples |
| US6696271B2 (en) * | 2001-08-23 | 2004-02-24 | The Regents Of The University Of California | Frozen tissue microarray technology for analysis of RNA, DNA, and proteins |
| WO2003091380A2 (en) * | 2002-04-24 | 2003-11-06 | Biogentis Inc. | Method for preparing tissue constructs |
| AU2004284461A1 (en) | 2003-10-23 | 2005-05-06 | Georgetown University | Method for two- and three-dimensional microassembly of patterns and structures |
| US7854899B2 (en) * | 2004-08-26 | 2010-12-21 | The United States Of America As Represented By The Secretary Of Health And Human Services | Template methods and devices for preparing sample arrays |
-
2004
- 2004-10-22 AU AU2004284461A patent/AU2004284461A1/en not_active Abandoned
- 2004-10-22 CA CA002543782A patent/CA2543782A1/en not_active Abandoned
- 2004-10-22 WO PCT/US2004/035209 patent/WO2005040348A2/en not_active Ceased
- 2004-10-22 EP EP04796242A patent/EP1681921A4/en not_active Withdrawn
-
2006
- 2006-04-24 US US11/409,717 patent/US8349584B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20060257908A1 (en) | 2006-11-16 |
| CA2543782A1 (en) | 2005-05-06 |
| WO2005040348A3 (en) | 2005-08-11 |
| US8349584B2 (en) | 2013-01-08 |
| EP1681921A2 (en) | 2006-07-26 |
| EP1681921A4 (en) | 2011-08-10 |
| WO2005040348A2 (en) | 2005-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8349584B2 (en) | Microarrays and their manufacture | |
| JP2003014756A (en) | Micro-array and its manufacturing method | |
| US20020015952A1 (en) | Microarrays and their manufacture by slicing | |
| US20030044855A1 (en) | Microarrays and their manufacture by slicing | |
| US20110252935A1 (en) | Device for dissecting thin samples and methods thereof | |
| WO1999044063B1 (en) | Tumor tissue microarrays for rapid molecular profiling | |
| EP1747065A1 (en) | Functionalized porous supports for microarrays | |
| US11320349B2 (en) | Spheroid tissue microarray and methods of manufacture | |
| US20110046017A1 (en) | Mold of recipient block and usage thereof | |
| US20240279643A1 (en) | Biochip for spatial transcriptomic analysis, manufacturing method therefor and application thereof | |
| CA2424176A1 (en) | Multiplexed cell analysis system | |
| CN116376662A (en) | Biochip for space transcriptome analysis, its preparation method and application | |
| DE10110511C1 (en) | Method for producing an array for the detection of components from a biological sample | |
| WO2024205435A1 (en) | Device and a system for generation of ordered arrays of cell microcarriers on a substrate | |
| WO2002010761A1 (en) | Microarrays and their manufacture by slicing | |
| DE102004005100A1 (en) | Process for the preparation of solid phase bound bioreagents | |
| KR101927890B1 (en) | Apparatus for Detecting Cell Performing Simultaneous Cell Culture and Detecting Based on Hydrogel and Microfluidic Channel | |
| WO2004090168A1 (en) | Multiplexed cell analysis system | |
| CN1242071C (en) | Drum type technique for preparing biochip in micro array mode | |
| Anderson | Microarrays and their manufacture by slicing | |
| US20100056380A1 (en) | Combinatorial biomineralization arrays | |
| CN1563419A (en) | Layered type technique for preparing biochip in micro array mode |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |